← Back to Search

Stereotactive body radiation therapy for Renal Masses (SBRT vs RFA Trial)

N/A
Waitlist Available
Led By Anil Kapoor, MD FRCSC
Research Sponsored by St. Joseph's Healthcare Hamilton
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients ≥18 years of age and capable of providing informed consent
Patients who are willing to have a biopsy 12 months post-procedure
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

SBRT vs RFA Trial Summary

This trial will compare two cancer treatments: RFA and SBRT. It will evaluate their short- and long-term efficacy and safety in the treatment of SRMs.

SBRT vs RFA Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

SBRT vs RFA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Disease free survival
Disease recurrence
Overall Survival
+1 more
Secondary outcome measures
Change in score for quality of life
Complication Rate
Cost analysis
+6 more

SBRT vs RFA Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Stereotactic body radiation therapy (SBRT)Experimental Treatment1 Intervention
Group II: Radiofrequency Ablation (RFA)Active Control1 Intervention

Find a Location

Who is running the clinical trial?

St. Joseph's Healthcare HamiltonLead Sponsor
195 Previous Clinical Trials
25,400 Total Patients Enrolled
Anil Kapoor, MD FRCSCPrincipal InvestigatorSt. Joseph's Healthcare Hamilton

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can persons still enroll in this trial?

"This particular trial, which was introduced on October 1st 2019 and last updated in December 14th 2021, is not actively recruiting. Yet, there are two other studies currently enrolling participants at this time."

Answered by AI

What are the desired outcomes of this experiment?

"This 12-month medical trial is primarily seeking to measure Overall Survival. Other endpoints include Renal Function -eGFR, Duration of Hospital Stay and Tumour Size. Each of these outcomes have been specified with particular metrics for accurate data collection."

Answered by AI
~4 spots leftby Mar 2025